Literature DB >> 10466685

Cardiological applications of nuclear medicine.

M Schwaiger1, J Melin.   

Abstract

Cardiovascular mortality is falling in most industrialised nations. Primarily responsible for this encouraging trend are preventive measures such as risk-factor modification but improved medical and surgical management have helped too. Clinical decision making in the patient with coronary heart disease demands techniques that not only describe coronary anatomy but also provide functional indices for early detection and to monitor the severity and extent of disease. Nuclear medicine methods can characterise non-invasively myocardial function, perfusion, and metabolism. Novel radiopharmaceuticals, improvements in imaging equipment, and extensive validation have contributed to the growing clinical acceptance of these techniques and to their cost-effective integration in the workup of patients with cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466685     DOI: 10.1016/S0140-6736(99)06057-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Myocardial perfusion imaging agents: SPECT and PET.

Authors:  George A Beller; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

Review 2.  PET and MRI in cardiac imaging: from validation studies to integrated applications.

Authors:  Stephan G Nekolla; Axel Martinez-Moeller; Antti Saraste
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

3.  Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses.

Authors:  Kengo Hatada; Mirta Ruiz; Laurent M Riou; Ronaldo L Lima; Allen R Goode; Denny D Watson; George A Beller; David K Glover
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

4.  64Cu-labeled 2-(diphenylphosphoryl)ethyldiphenylphosphonium cations as highly selective tumor imaging agents: effects of linkers and chelates on radiotracer biodistribution characteristics.

Authors:  Chang-Tong Yang; Young-Seung Kim; Jianjun Wang; Lijun Wang; Jiyun Shi; Zi-Bo Li; Xiaoyuan Chen; Ming Fan; Jian-Jian Li; Shuang Liu
Journal:  Bioconjug Chem       Date:  2008-09-03       Impact factor: 4.774

Review 5.  Emerging Tracers for Nuclear Cardiac PET Imaging.

Authors:  Dong-Yeon Kim; Sang-Geon Cho; Hee-Seung Bom
Journal:  Nucl Med Mol Imaging       Date:  2018-05-08

6.  Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography.

Authors:  F B Sozzi; D Poldermans; J J Bax; A Elhendy; E C Vourvouri; R Valkema; J De Sutter; A F Schinkel; A Borghetti; J R Roelandt
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

7.  Comparison of the Cardiac MicroPET Images Obtained Using [(18)F]FPTP and [(13)N]NH3 in Rat Myocardial Infarction Models.

Authors:  Dong-Yeon Kim; Hyeon Sik Kim; Hwa Youn Jang; Ju Han Kim; Hee-Seung Bom; Jung-Joon Min
Journal:  ACS Med Chem Lett       Date:  2014-09-10       Impact factor: 4.345

8.  BMS-747158-02: a novel PET myocardial perfusion imaging agent.

Authors:  Ming Yu; Mary T Guaraldi; Mahesh Mistry; Mikhail Kagan; Jennifer L McDonald; Kenneth Drew; Heike Radeke; Michael Azure; Ajay Purohit; David S Casebier; Simon P Robinson
Journal:  J Nucl Cardiol       Date:  2007-10-22       Impact factor: 5.952

Review 9.  Radiolabeled Phosphonium Salts as Mitochondrial Voltage Sensors for Positron Emission Tomography Myocardial Imaging Agents.

Authors:  Dong-Yeon Kim; Jung-Joon Min
Journal:  Nucl Med Mol Imaging       Date:  2016-02-29

10.  Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates.

Authors:  Ming Yu; Mary Guaraldi; Mikhail Kagan; Mahesh Mistry; Jennifer McDonald; Jody Bozek; Padmaja Yalamanchili; Megan Hayes; Michael Azure; Ajay Purohit; Heike Radeke; David S Casebier; Simon P Robinson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-21       Impact factor: 9.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.